These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7639234

  • 21. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S, Iijima H, Nakagawa T, Egawa S, Nakajima S, Ishii S, Irie T, Kakiuchi Y, Nishida T, Yasumaru M, Kanto T, Tsujii M, Tsuji S, Mizushima T, Yoshihara H, Kondo A, Miyoshi E, Hayashi N.
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [Abstract] [Full Text] [Related]

  • 22. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H.
    Nutrition; 2008 May; 24(7-8):694-702. PubMed ID: 18499398
    [Abstract] [Full Text] [Related]

  • 23. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K.
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [Abstract] [Full Text] [Related]

  • 24. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K, Berger M, Niederau C, Frieling T.
    Hepatogastroenterology; 1999 Feb; 46(28):2309-14. PubMed ID: 10521988
    [Abstract] [Full Text] [Related]

  • 25. Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease.
    Seidelin JB, Vainer B, Horn T, Nielsen OH.
    Am J Gastroenterol; 1998 Oct; 93(10):1854-9. PubMed ID: 9772044
    [Abstract] [Full Text] [Related]

  • 26. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, Nakagawa K, Tanaka S, Teranishi T, Hirata I, Katsu K.
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [Abstract] [Full Text] [Related]

  • 27. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 May; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T, Lim C, Shimoda K, Shibuta K, Mitra P, Banner BF, Mori M, Barnard GF.
    Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
    [Abstract] [Full Text] [Related]

  • 29. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I, Fedak D, Mach T.
    Przegl Lek; 2010 Nov; 67(12):1262-5. PubMed ID: 21591350
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, Parhofer KG, Göke B, Broedl UC.
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD, Bid HK, Ghoshal UC.
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [Abstract] [Full Text] [Related]

  • 34. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G, Betzler M, Post S, Herfarth C, Meuer S.
    Digestion; 1992 Jul; 51(1):51-9. PubMed ID: 1639222
    [Abstract] [Full Text] [Related]

  • 35. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI, Al-Harthi SE, Al-Mughales JA, Bin-Taleb YY, Baeshen RS.
    Int J Clin Exp Pathol; 2015 Jul; 8(12):16000-6. PubMed ID: 26884875
    [Abstract] [Full Text] [Related]

  • 36. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
    Kucharzik T, Stoll R, Lügering N, Domschke W.
    Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED, Laxer RM, Nelson DL, Rubin LA.
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [Abstract] [Full Text] [Related]

  • 40. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
    Vainer B, Nielsen OH, Hendel J, Horn T, Kirman I.
    Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.